Trial Profile
A Retrospective study to evaluate the safety, tolerability and efficacy of Nano-liposomal irinotecan and fluorouracil + folinic acid (leucovorin) in patients with advanced Pancreatic Adenocarcinoma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Feb 2018
Price :
$35
*
At a glance
- Drugs Irinotecan (Primary) ; Fluorouracil; Folinic acid
- Indications Pancreatic cancer
- Focus Adverse reactions; Therapeutic Use
- 22 Feb 2018 New trial record
- 20 Jan 2018 Results presented at the 2018 Gastrointestinal Cancers Symposium